Subgroup analyses from the VISION (Guardant360) and GEOMETRY mono-1 (FoundationOne CDx) studies reported frequent co-mutations in METex14 NSCLC, most commonly involving TP53, MDM2, and CDKN2A. This evidence concerns the gene TP53 and non-small cell lung carcinoma.